ArticleBriefings in bioinformatics2025
ConvNTC: convolutional neural tensor completion for detecting "A-A-B" type biological triplets.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Systematically investigating interactions among molecules of the same type across different contexts is crucial for unraveling disease mechanisms and developing potential therapeutic strategies. The "A-A-B" triplet paradigm provides a principled approach to model such context-specific interactions, and leveraging third-order tensor to capture such type ternary relationships is an efficient strategy. However, effectively modeling both multilinear and nonlinear characteristics to accurately identify such triplets using tensor-based methods remains a challenge. In this paper, we propose a novel Convolutional Neural Tensor Completion (ConvNTC) framework that collaboratively learns the multilinear and nonlinear representations to model triplet-based network interactions. ConvNTC consists of a multilinear module and a nonlinear module. The former is a tensor decomposition approach that integrates multiple constraints to learn the tensor factor embeddings. The latter contains three components: an embedding generator to produce position-specific index embeddings for each tensor entry in addition to the factor embeddings, a convolutional encoder to perform nonlinear feature mapping while preserving the tensor's rank-one property, and a Kolmogorov-Arnold Network (KAN) based predictor to effectively capture high-dimensional relationships aligned with the intrinsic structure of real-world data. We evaluate ConvNTC on two types triplet datasets of the "A-A-B" type: miRNA-miRNA-disease and drug-drug-cell. Comprehensive experiments against 11 state-of-the-art methods demonstrate the superiority of ConvNTC in terms of triplet prediction. ConvNTC reveals promising prognostic values of the miRNA-miRNA interactions on breast cancer and detects synergistic drug combinations in cancer cell lines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.